Elmiron Lawyers in Columbus, OH
What is Elmiron?
Elmiron is a medication used to treat a chronic condition called interstitial cystitis, bladder and pelvic pain. Recently, scientific research has discovered a link between Elmiron and pigmentary maculopathy—one of the leading causes of blindness in American adults. Symptoms of maculopathy, or macular degeneration, can include gradual loss of vision, blurry vision, sensitivity to light and loss of low-light visibility. Unfortunately, these symptoms can be irreversible.
Were you taking Elmiron?
Elmiron and Its Risks
Elmiron is a popular medication used to treat interstitial cystitis and painful bladder syndrome. According to the Urology Care Foundation, they estimate that 1 to 4 million men and 3 to 8 million women have symptoms of IC/BPS. At the moment, Elmiron is the only FDA approved medication to treat this condition. Because of this fact, thousands of people have been exposed to this medication and its side effects over many years. Doctors recommend patients consult with their urologist regarding their use of this medication along with yearly screenings for patients who are not currently exhibiting signs of pigmentary maculopathy.
The drug has recently been associated with a significantly increased risk of pigmentary maculopathy, which results from chronic and permanent damage to the retina. Injuries can range from irreparable vision impairment to blindness, which can progress even after patients stop taking the drug.
Specific diagnoses and side effects of Elmiron include:
• Blindness (bilateral)
• Blurred vision
• Macular degeneration
• Pattern Dystrophy
• Pigmentary maculpathy
• Vision disturbances
• Vision impairment
• Vision loss
Do you believe your eye problems are linked to Elmiron?
Are You Eligible for a Claim?
If you or a loved one has developed blindness after taking Elmiron, you may be eligible for compensation. Contact our attorneys for a free consultation to discuss your potential case.
Like millions of Americans, you may have taken this drug that was deemed to be safe and effective. Now you may be unfortunately stricken with a life-threatening disease that will physically, emotionally, and financially burden you and your loved ones. Let us help you and your family get justice. Call us today! You will receive:
- Free consultation over the phone
- Easy consultation, with no obligations
- Case review from an experienced drug injury lawyer
More About Dangerous Drugs
If you or a loved one has been harmed by a dangerous drug, such as Elmiron, contact us for a free consultation today. You may be entitled to financial compensation.
RECENT BLOG POSTS ABOUT DANGEROUS DRUGS
Never Events & Medical Malpractice Claims
Do you need advice from a medical malpractice attorney in Columbus? Medical treatment is never without risk, but the benefits should outweigh the risks. In most cases, it does – but mistakes happen. Some don’t lead to serious harm, but there are certain errors that no...
Elmiron & Blindness
Clark Perdue is proud of its decades long of counsel relationship with Anapol Weiss. The collaborative effort between our firms has proven effective time and again in the representation of our mutual clients. We are pleased to announce that Anapol Weiss' Senior...
FDA Proposes Recall of Zantac
The Food and Drug Administration has requested drug manufacturers recall the popular heart burn medication, Zantac. This move comes as a continuing FDA investigation has found that Zantac, and other drugs with the active ingredient ranitidine, often contain...
Zantac Linked to Cancer Risk When Stored in High Heat
In a previous post, we wrote about the FDA's investigation into the heartburn medication, Zantac, and other drugs containing ranitidine. The problem is that ranitidine has been found to contain N-Nitrosodimethylamine (“NDMA”), a suspected cancer causing agent in...
Zantac Cancer Risk
Zantac, a popular heartburn medication, has been pulled from major retailers shelves because some of its ingredients may be linked to Zantac cancer risk. The Food and Drug Administration ("FDA") continues to investigate the Zantac cancer risk, noting that "FDA is...
Taxotere Hair Loss MDL Ordered
The Judicial Panel on Multidistrict Litigation ordered consolidation of all Taxotere hair loss cases on October 2, 2016. The panel noted that nearly 90 cases, alleging permanent hair loss resulting for the use of the chemotherapy drug, Taxotere, have been filed...